Merck’s Fosamax is a widely used bone building drug, a piphosphonate used to treat osteoperosis. This potentially helpful drug has been found to have a severe defect – it has been directly linked to osteonecrosis of the jaw, wherein the jaw deteriorates in a painful and disfiguring manner. Many victims of osteonecrosis of the jaw can no longer manage the consumption of solid food.
Symptoms of osteonecrosis of the jaw include:
- Loosening or loss of teeth
- Drainage of the gums
- Pain and swelling of the gums
One of many disadvantages of contracting the disease from Fosamax is that the victim may have stopped taking the drug for years, as traces of the drug can remain lingering in the human system long after digestion. The disease can and is generally obtained from dental trauma from dental surgery.
If you or someone you know has contracted osteonecrosis of the jaw from Fosamax or has suffered personal injury from another defective product, please feel free to contact personal injury attorneys Jacoby and Meyers of Los Angeles, California.
